Cargando…

CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study

PURPOSE: Genetic susceptibility could be modified by environmental factors and may also influence differential responses to treatments for age-related macular degeneration (AMD). We investigated whether genotype could influence response to docosahexaenoic acid (DHA)-supplementation in the occurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merle, Bénédicte M. J., Richard, Florence, Benlian, Pascale, Puche, Nathalie, Delcourt, Cécile, Souied, Eric H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489493/ https://www.ncbi.nlm.nih.gov/pubmed/26132079 http://dx.doi.org/10.1371/journal.pone.0130816

Ejemplares similares

A69S and R38X ARMS2 and Y402H CFH gene polymorphisms as risk factors for neovascular age-related macular degeneration in Poland – a brief report
por: Teper, Sławomir J., et al.
Publicado: (2012)

Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients
por: Krytkowska, Elżbieta, et al.
Publicado: (2021)

Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial
por: Querques, Giuseppe, et al.
Publicado: (2016)

Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration
por: Supanji, Supanji, et al.
Publicado: (2021)

Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration
por: Kim, Ivana K., et al.
Publicado: (2008)

Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population
por: Fang, Kai, et al.
Publicado: (2015)

Association between CFH Y402H Polymorphism and Age Related Macular Degeneration in North Indian Cohort
por: Sharma, Neel Kamal, et al.
Publicado: (2013)

CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation
por: Vavvas, Demetrios G., et al.
Publicado: (2018)

DHA supplementation for late onset Stargardt disease: NAT-3 study
por: Querques, Giuseppe, et al.
Publicado: (2010)

A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
por: Sivakumaran, Theru A., et al.
Publicado: (2011)

Correction: A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
por: Sivakumaran, Theru A., et al.
Publicado: (2018)

Association between Polymorphisms in CFH, ARMS2, CFI, and C3 Genes and Response to Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration
por: Kozhevnikova, Oyuna S., et al.
Publicado: (2022)

Exogenous CFH Modulates Levels of Pro-Inflammatory Mediators to Prevent Oxidative Damage of Retinal Pigment Epithelial Cells with the At-Risk CFH Y402H Variant
por: Velazquez-Soto, Henry, et al.
Publicado: (2023)

CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD
por: Magnusson, Kristinn P, et al.
Publicado: (2006)

Associations of MicroRNAs, Angiogenesis-Regulating Factors and CFH Y402H Polymorphism—An Attempt to Search for Systemic Biomarkers in Age-Related Macular Degeneration
por: Ulańczyk, Zofia, et al.
Publicado: (2019)

Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking
por: Hughes, Anne E, et al.
Publicado: (2007)

Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2012)

CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye
por: Wang, Jay Ching Chieh, et al.
Publicado: (2015)

Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran
por: Nazari Khanamiri, Hossein, et al.
Publicado: (2014)

CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans
por: Contreras, Alejandra V., et al.
Publicado: (2014)

Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel
por: Chowers, Itay, et al.
Publicado: (2008)

Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration
por: Menghini, Moreno, et al.
Publicado: (2012)

The ALGOVUE Clinical Trial: Effects of the Daily Consumption of Eggs Enriched with Lutein and Docosahexaenoic Acid on Plasma Composition and Macular Pigment Optical Density
por: Schnebelen-Berthier, Coralie, et al.
Publicado: (2021)

Progression from Type 2 Macular Neovascularization to Fibrovascular Pigment Epithelial Detachment
por: LE, Hoang Mai, et al.
Publicado: (2021)

Genetic association study of mitochondrial polymorphisms in neovascular age-related macular degeneration
por: Tilleul, Julien, et al.
Publicado: (2013)

Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
por: Kim, Kyoung Lae, et al.
Publicado: (2022)

Multifactor Effects and Evidence of Potential Interaction between Complement Factor H Y402H and LOC387715 A69S in Age-Related Macular Degeneration
por: Seitsonen, Sanna P., et al.
Publicado: (2008)

Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration
por: Nan, Ruodan, et al.
Publicado: (2011)

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
por: Tilleul, Julien, et al.
Publicado: (2014)

Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci
por: Pappas, Chris M., et al.
Publicado: (2021)

InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years
por: Cozzupoli, Grazia M., et al.
Publicado: (2022)

Undetectable Macular Neovascularization on OCT Angiography in Age Related Macular Degeneration: Comparison between Different Devices
por: Filali Ansary, Meryem, et al.
Publicado: (2022)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
por: Muth, Daniel Rudolf, et al.
Publicado: (2022)

Progression of Age-Related Macular Degeneration Among Individuals Homozygous for Risk Alleles on Chromosome 1 (CFH-CFHR5) or Chromosome 10 (ARMS2/HTRA1) or Both
por: Schmitz-Valckenberg, Steffen, et al.
Publicado: (2022)

Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population
por: Francis, Peter J, et al.
Publicado: (2008)

CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD
por: Scholl, Hendrik P. N., et al.
Publicado: (2009)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
por: Razavi, Sam, et al.
Publicado: (2021)

Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia
por: Tiis, Roza Pavlovna, et al.
Publicado: (2020)

A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
por: Raychaudhuri, Soumya, et al.
Publicado: (2011)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5bg6k9m1l2d4rc1sdfqka0ggr4